多参数MRI检测与分期放疗后复发前列腺癌
单中心回顾性研究纳入24例放疗后局部复发并接受挽救性前列腺切除术的患者,以全标本病理为参考标准,评估多参数MRI检测局部复发和包膜外侵犯的敏感度与特异度。按PI-RADS v2,敏感度64%、特异度94%;MP-MRI对复发癌分期不足者占63%。将DCE作为共同主导序列的改良评分系统在亚组分析中使诊断敏感度由61%提高至76%。
要点
- 放疗后复发前列腺癌的MP-MRI检测敏感度中等(64%)、特异度 high(94%),但容易低估病变范围和分期。
- 按PI-RADS v2,MP-MRI对63%的复发病例分期不足。
- 将DCE作为共同主导序列的改良评分可提高诊断敏感度(亚组分析中由61%升至76%)。
诊断标准与关键数值
- 按PI-RADS v2评估MP-MRI检测局部复发的敏感度64%、特异度94%、阳性预测值98%、阴性预测值36%。
- MP-MRI对复发癌分期不足者占63%。
- 采用DCE作为共同主导序列的改良评分系统,亚组分析中诊断敏感度由61%提高至76%。
局限性
- 本研究为单中心回顾性研究。
- 作者结论指出MP-MRI对放疗后复发前列腺癌倾向于低估病变范围和分期不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: We determined the sensitivity and specificity of multiparametric magnetic resonance imaging (MP-MRI) in detection of locally recurrent prostate cancer and extra prostatic extension in the post-radical radiotherapy setting. Histopathological reference standard was whole-mount prostatectomy specimens. We also assessed for any added value of the dynamic contrast enhancement (DCE) sequence in detection and staging of local recurrence.
METHODS: This was a single centre retrospective study. Participants were selected from a database of males treated with salvage prostatectomy for locally recurrent prostate cancer following radiotherapy. All underwent pre-operative prostate-specific antigen assay, positron emission tomography CT, MP-MRI and transperineal template prostate mapping biopsy prior to salvage prostatectomy. MP-MRI performance was assessed using both Prostate Imaging-Reporting and Data System v. 2 and a modified scoring system for the post-treatment setting.
RESULTS: 24 patients were enrolled. Using Prostate Imaging-Reporting and Data System v. 2, sensitivity, specificity, positive predictive value and negative predictive value was 64%, 94%, 98% and 36%. MP-MRI under staged recurrent cancer in 63%. A modified scoring system in which DCE was used as a co-dominant sequence resulted in improved diagnostic sensitivity (61%-76%) following subgroup analysis.
CONCLUSION: Our results show MP-MRI has moderate sensitivity (64%) and high specificity (94%) in detecting radio-recurrent intraprostatic disease, though disease tends to be under quantified and under staged. Greater emphasis on dynamic contrast images in overall scoring can improve diagnostic sensitivity.
ADVANCES IN KNOWLEDGE: MP-MRI tends to under quantify and under stage radio-recurrent prostate cancer. DCE has a potentially augmented role in detecting recurrent tumour compared with the de novo setting. This has relevance in the event of any future modified MP-MRI scoring system for the irradiated gland.
引用
- Kowa JY, Soneji N, Sohaib SA, et al. Detection and staging of radio-recurrent prostate cancer using multiparametric MRI. Br J Radiol. 2021. PMID: 33586998. doi:10.1259/bjr.20201423
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。